Skip to main content
. Author manuscript; available in PMC: 2021 Sep 28.
Published in final edited form as: Cancer Lett. 2020 May 30;488:40–49. doi: 10.1016/j.canlet.2020.05.027

Fig. 4.

Fig. 4.

MTM intensifies effectiveness of DNA damaging agent in PCa. A, Western blot of DNA repair-related genes in MTM and Bleomycin co-treated 22RV1 cells. B, Western blot of DNA repair-related genes in MTM and Bleomycin co-treated VCaP cells. C, Representative images of clonogenic assay of 22RV1 cells upon MTM and Bleomycin co-treatment. D, Quantification of colonies in clonogenic assay of 22RV1 cells in C.